Piramal Enterprises acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.
Piramal Enterprises Ltd has informed BSE regarding a Press Release dated January 16, 2015 titled "Piramal Enterprises acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc." Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.
Piramal Enterprises Ltd has informed BSE regarding a Press Release dated January 15, 2015 titled "Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc." Piramal Enterprises Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Piramal Enterprises Ltd with respect to news appearing in The Financial Express on January 14, 2015 titled "Piramal's pharma arm to invest $40 m in new tech."Piramal Enterprises Ltd replied stating "As part of its strategy, the Company's Pharma Solutions division continually looks at viable investment opportunities for augmenting its existing capacity and adding new capabilities, including by way... Clarification sought from Piramal Enterprises Ltd
The Exchange has sought clarification from Piramal Enterprises Ltd with respect to news article appearing in The Financial Express on January 14, 2015 titled "Piramal's pharma arm to invest $40 m in new tech."The reply is awaited. Clarifies on News item
With reference to the news item appearing in the news channel titled "Piramal Enterprises have acquired 2 BOT Infra Projects from Supreme Infra worth Rs. 700 crores., Piramal Enterprises Ltd has Clarified to BSE as under:"The Company from time to time explores various investment opportunities as part of its structured investment business, in the normal course of its business. This evaluation of opportunities includes various criteria, including... Re-appointment of Executive Director
Piramal Enterprises Ltd has informed BSE that Mr. Vijay Shah, Executive Director of the Company whose current tenure was expiring on December 31, 2014 has been re-appointed as the Whole Time Director of the Company, designated as Executive Director, for a further period of 3 years with effect from January 01, 2015.The above appointment is subject to the approval of the shareholders and applicable regulatory approvals. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Piramal Enterprises Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Chunduru Srinivas has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Piramal Enterprises Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Vijay Kantilal Shah has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992